PCP
BSX icon

Pacific Capital Partners’s Boston Scientific BSX Stock Holding History

Pacific Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,156
Closed -$1.18M – 44
2024
Q4 		$1.18M Hold
13,156
– – 0.69% 37
2024
Q3 		$1.1M Hold
13,156
– – 0.65% 39
2024
Q2 		$1.01M Sell
13,156
-5,088
-28% -$372K 0.67% 45
2024
Q1 		$1.25M Hold
18,244
– – 0.82% 36
2023
Q4 		$1.05M Buy
18,244
+331
+2% +$17.7K 0.8% 35
2023
Q3 		$946K Buy
+17,913
New +$939K 0.57% 38

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pacific Capital Partners's BSX Position: Q1 2025 in Review

Pacific Capital Partners sold out of Boston Scientific (BSX) in Q1 2025, closing a stake of 13,156 shares — an estimated $1.18M sold.

Pacific Capital Partners first reported a position in BSX in Q3 2023 and held it in 6 quarters. The position peaked at $1.25M in Q1 2024. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Pacific Capital Partners reported no remaining Boston Scientific position as of Q1 2025 after selling out during the quarter.
  • Pacific Capital Partners sold 13,156 Boston Scientific shares in Q1 2025, an estimated $1.18M.
  • Pacific Capital Partners first reported a position in Boston Scientific in Q3 2023 and held it in 6 quarters.
  • Pacific Capital Partners's Boston Scientific position peaked at $1.25M in Q1 2024.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Pacific Capital Partners's 13F filing for Q1 2025, filed 8 May 2025.